Agency Forms Undergoing Paperwork Reduction Act Review, 5101-5102 [2018-02205]
Download as PDF
Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
395–5806. Provide written comments
within 30 days of notice publication.
Centers for Disease Control and
Prevention
Proposed Project
Implementing the 6|18 Initiative: Case
Studies—New—Office of the Director
(OD), Centers for Disease Control and
Prevention (CDC).
[30Day–18–17BAM]
sradovich on DSK3GMQ082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Implementing
the 6/18 Initiative: Case Studies to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on October 13, 2017 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
VerDate Sep<11>2014
18:08 Feb 02, 2018
Jkt 244001
Background and Brief Description
Major trends in health care, such as
alternative payment and delivery
models, facilitate the delivery of greater
comprehensive care and prevention.
Public health departments have
leveraged their resources to complement
those of the health care sector, to impact
population health.
In this context, CDC developed the
CDC’s 6|18 Initiative to provide health
care purchasers, payers, and providers
with rigorous evidence about highburden health conditions and associated
evidence-based interventions. With a
focus on the greatest short-term health
and potential cost impact (generally in
less than five years), the evidence
informs their coverage decisions.
The name ‘‘6|18’’ comes from the
initial focus on six common, costly and
preventable health conditions (tobacco
use, high blood pressure, diabetes,
asthma, healthcare-associated infections
and unintended pregnancies) and 18
evidence-based interventions. For more
information, please see https://
www.cdc.gov/sixeighteen.
The 6|18 initiative links health care
and public health by providing a shared
focus across prevention interventions
ranging from traditional clinical settings
to care outside the clinical setting.
Public health’s strength in analyzing
scientific evidence complements the
purchaser, payer, and provider role of
financing and delivering care.
Since public health-health care
collaboration to improve population
health is still not a standard practice,
there are few or no case studies on
public health-health care collaboration
around increasing preventive service
utilization. CDC intends to fill this gap
through this data collection.
CDC and its partners provided
technical assistance to 17 teams (i.e.,
from Medicaid and Public Health
Agencies) from states, the District of
Columbia, and a large city (hereafter,
‘‘states’’), to support their
implementation of the 6|18 Initiative’s
interventions. No data has been
collected to date.
To document qualitative lessons
learned related to the collaboration,
CDC and its cooperative agreement subcontractor, George Washington
University, plan to conduct in-person
and telephone semi-structured
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
5101
individual interviews with state Public
Health Department and State Medicaid
Agency officials.
Interview participants will have been
directly involved in conceptualizing,
planning, and/or implementing 6|18
Initiative-related activities, and will
have participated in the cross-sector
collaboration. CDC plans to engage up to
82 respondents (four to seven officials
from each of the 17 state teams who
participated in the 6|18 Initiative). The
officials from each state team will be
leadership and staff from public health
agencies at the state, city, and tribal
level. For each state, we will request
interviews with: One Public Health
Division Director, one to four Public
Health Services Managers (one per
health condition), one Medicaid
Director, and one Medicaid Services
Manager. When joining the 6|18
Initiative, each state selected one to four
conditions from the list of 6|18
conditions, and assigned one public
health manager to each condition.
CDC plans to administer the
interviews from 2018 to 2021, to allow
time for unanticipated delays; and to
accommodate state team schedules,
busy seasons, and holidays. All
participants will speak in their official
capacity as state public health
department or Medicaid agency
officials. Prior to granting public access
to written products, CDC will provide
participants the opportunity to review
written products.
CDC anticipates using the interview
findings: (1) To describe, disseminate,
and scale best practices to participating
and non-participating states, and (2) for
program improvement of the CDC’s 6|18
Initiative. CDC will disseminate
findings via written products such as
peer-reviewed manuscripts and indepth written case studies. The written
products, which will share lessons
learned and effective approaches to
collaboration, can inform and
potentially accelerate related efforts by
other state teams. In addition, 6|18
participants can use findings and
written products to highlight their
accomplishments to their stakeholders,
such as their Medicaid leadership, and/
or governors.
Participants will have a maximum
estimated burden of one hour and 15
minutes: One hour for the interview,
and fifteen minutes for any needed
preparation. All interviews will be
based on the same interview guide.
OMB approval is requested for three
years. An annualized average of 29
interviews will be conducted per year.
Participation is voluntary and
respondents will not receive incentives
for participation. There are no costs to
E:\FR\FM\05FEN1.SGM
05FEN1
5102
Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices
respondents other than their time. The
total estimated annualized burden hours
are 38.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
State
State
State
State
Public Health Director ...........................
Public Health Manager ..........................
Medicaid Director ..................................
Medicaid Manager .................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–02205 Filed 2–2–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[60Day–18–0307; Docket No. CDC–2018–
0019]
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Gonococcal Isolate Surveillance
Project (GISP)’’. The purpose of GISP is
to monitor trends in antimicrobial
resistance in N. gonorrhoeae strains in
the United States in order to establish a
scientific basis for the selection of
gonococcal therapies and to allow
proactive changes to treatment
guidelines before widespread resistance
and failures of treatment occur.
DATES: CDC must receive written
comments on or before April 6, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0019 by any of the following methods:
sradovich on DSK3GMQ082PROD with NOTICES
Jkt 244001
..............................................
..............................................
..............................................
..............................................
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions for
submitting comments.
• Mail: Leroy A. Richardson, Information
Collection Review Office, Centers for Disease
Control and Prevention, 1600 Clifton Road
NE, MS–D74, Atlanta, Georgia 30329.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
FOR FURTHER INFORMATION CONTACT:
Proposed Data Collection Submitted
for Public Comment and
Recommendations
18:08 Feb 02, 2018
Guide
Guide
Guide
Guide
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
Centers for Disease Control and
Prevention
VerDate Sep<11>2014
Interview
Interview
Interview
Interview
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
BILLING CODE 4163–18–P
SUMMARY:
Number of
respondents
Form name
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
6
11
6
6
Number of
responses
per
respondent
Average
burden per
response
(in hours)
1
1
1
1
75/60
75/60
75/60
75/60
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Gonococcal Isolate Surveillance
Project (OMB Control Number 0920–
0307, Expiration 2/28/2019)—
Revision—National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Gonococcal Isolate Surveillance
Project (GISP) was created in 1986 to
monitor trends in antimicrobial
susceptibilities of N. gonorrhoeae
strains in the United States. Data from
GISP are used to establish a scientific
basis for the selection of gonococcal
therapies and to allow pro-active
changes to treatment guidelines before
widespread resistance and failures of
treatment occur. To increase capacity to
detect and monitor resistant gonorrhea
and improve the specificity of GISP, this
submission is a revision to include
collection of additional isolates and data
elements.
The Centers for Disease Control and
Prevention has designated N.
gonorrhoeae as one of three ‘‘urgent’’
antibiotic resistance threats in the
United States. The CDC is requesting a
three-year OMB approval for this
revision, which directly responds to the
E:\FR\FM\05FEN1.SGM
05FEN1
Agencies
[Federal Register Volume 83, Number 24 (Monday, February 5, 2018)]
[Notices]
[Pages 5101-5102]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02205]
[[Page 5101]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-17BAM]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Implementing the 6/18 Initiative: Case
Studies to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on October
13, 2017 to obtain comments from the public and affected agencies. CDC
did not receive comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Implementing the 6[bond]18 Initiative: Case Studies--New--Office of
the Director (OD), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Major trends in health care, such as alternative payment and
delivery models, facilitate the delivery of greater comprehensive care
and prevention. Public health departments have leveraged their
resources to complement those of the health care sector, to impact
population health.
In this context, CDC developed the CDC's 6[bond]18 Initiative to
provide health care purchasers, payers, and providers with rigorous
evidence about high-burden health conditions and associated evidence-
based interventions. With a focus on the greatest short-term health and
potential cost impact (generally in less than five years), the evidence
informs their coverage decisions.
The name ``6[bond]18'' comes from the initial focus on six common,
costly and preventable health conditions (tobacco use, high blood
pressure, diabetes, asthma, healthcare-associated infections and
unintended pregnancies) and 18 evidence-based interventions. For more
information, please see https://www.cdc.gov/sixeighteen.
The 6[bond]18 initiative links health care and public health by
providing a shared focus across prevention interventions ranging from
traditional clinical settings to care outside the clinical setting.
Public health's strength in analyzing scientific evidence complements
the purchaser, payer, and provider role of financing and delivering
care.
Since public health-health care collaboration to improve population
health is still not a standard practice, there are few or no case
studies on public health-health care collaboration around increasing
preventive service utilization. CDC intends to fill this gap through
this data collection.
CDC and its partners provided technical assistance to 17 teams
(i.e., from Medicaid and Public Health Agencies) from states, the
District of Columbia, and a large city (hereafter, ``states''), to
support their implementation of the 6[bond]18 Initiative's
interventions. No data has been collected to date.
To document qualitative lessons learned related to the
collaboration, CDC and its cooperative agreement sub-contractor, George
Washington University, plan to conduct in-person and telephone semi-
structured individual interviews with state Public Health Department
and State Medicaid Agency officials.
Interview participants will have been directly involved in
conceptualizing, planning, and/or implementing 6[bond]18 Initiative-
related activities, and will have participated in the cross-sector
collaboration. CDC plans to engage up to 82 respondents (four to seven
officials from each of the 17 state teams who participated in the
6[bond]18 Initiative). The officials from each state team will be
leadership and staff from public health agencies at the state, city,
and tribal level. For each state, we will request interviews with: One
Public Health Division Director, one to four Public Health Services
Managers (one per health condition), one Medicaid Director, and one
Medicaid Services Manager. When joining the 6[bond]18 Initiative, each
state selected one to four conditions from the list of 6[bond]18
conditions, and assigned one public health manager to each condition.
CDC plans to administer the interviews from 2018 to 2021, to allow
time for unanticipated delays; and to accommodate state team schedules,
busy seasons, and holidays. All participants will speak in their
official capacity as state public health department or Medicaid agency
officials. Prior to granting public access to written products, CDC
will provide participants the opportunity to review written products.
CDC anticipates using the interview findings: (1) To describe,
disseminate, and scale best practices to participating and non-
participating states, and (2) for program improvement of the CDC's
6[bond]18 Initiative. CDC will disseminate findings via written
products such as peer-reviewed manuscripts and in-depth written case
studies. The written products, which will share lessons learned and
effective approaches to collaboration, can inform and potentially
accelerate related efforts by other state teams. In addition, 6[bond]18
participants can use findings and written products to highlight their
accomplishments to their stakeholders, such as their Medicaid
leadership, and/or governors.
Participants will have a maximum estimated burden of one hour and
15 minutes: One hour for the interview, and fifteen minutes for any
needed preparation. All interviews will be based on the same interview
guide.
OMB approval is requested for three years. An annualized average of
29 interviews will be conducted per year. Participation is voluntary
and respondents will not receive incentives for participation. There
are no costs to
[[Page 5102]]
respondents other than their time. The total estimated annualized
burden hours are 38.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
State Public Health Director....... Interview Guide............ 6 1 75/60
State Public Health Manager........ Interview Guide............ 11 1 75/60
State Medicaid Director............ Interview Guide............ 6 1 75/60
State Medicaid Manager............. Interview Guide............ 6 1 75/60
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-02205 Filed 2-2-18; 8:45 am]
BILLING CODE 4163-18-P